Skip to main content
Clinical Trials/NCT05101083
NCT05101083
Completed
N/A

Speech Intelligibility in Quiet and Noise for New Versus Legacy Hearing Aids

Starkey Laboratories, Inc1 site in 1 country34 target enrollmentOctober 25, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Hearing Loss, Sensorineural
Sponsor
Starkey Laboratories, Inc
Enrollment
34
Locations
1
Primary Endpoint
Speech intelligibility (% words repeated back correctly) in quiet and noise for new vs. legacy hearing aids
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This clinical investigation is designed to compare audiological performance (i.e., measurements of sound quality and speech understanding) between Starkey's new receiver-in-canal device and a commercially available legacy receiver-in-canal device.

Detailed Description

Starkey is investigating a new hearing aid with several new audiological features. These features have been assessed for benefit, individually, but this clinical investigation will serve as a test for safety and efficacy with all hearing aid features, together. The design of this study is a single-blinded, crossover design and will be conducted at Starkey's headquarters in Eden Prairie, MN.

Registry
clinicaltrials.gov
Start Date
October 25, 2021
End Date
January 10, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adults, minimum age of 18
  • Native English speakers
  • Ability to complete questionnaires and laboratory assessments
  • Symmetric, mild to moderately-severe sensorineural hearing loss
  • Informed consent completed with signature

Exclusion Criteria

  • Inability to visit the Starkey Headquarters building for testing
  • Central or middle ear hearing problems
  • Medical contraindications to wearing hearing aids
  • Learning disability, major cognitive handicap, or serious neurological or psychiatric disease that would prevent or restrict participation, as determined by the PI or designee

Outcomes

Primary Outcomes

Speech intelligibility (% words repeated back correctly) in quiet and noise for new vs. legacy hearing aids

Time Frame: Four weeks

IEEE sentences will be presented to the research participants in quiet and in background noise. The percent words repeated back correctly will be scored and serve as the reported result of this outcome measure.

Secondary Outcomes

  • First fit ratings of sound quality on subjective questionnaires for the new vs. legacy hearing aids(Four weeks)
  • Safety of the new, receiver-in-canal devices through tracking of adverse events(Four weeks)

Study Sites (1)

Loading locations...

Similar Trials